Effect of the extract of the tamarind (Tamarindus indica) fruit on the complement system: Studies in vitro and in hamsters submitted to a cholesterol-enriched diet

Food and Chemical Toxicology

Volumn 45, Issue 8, 2007, Pages 1487-1495

  Landi Librandi, Ana Paula ^a   Chrysóstomo, Taís Nader ^a   Azzolini, Ana Elisa C S ^a   Recchia, Carem Gledes Vargas ^a   Uyemura, Sérgio Akira ^a   de Assis Pandochi, Ana Isabel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Complement system; Hamsters; Hyperlipidemia; Tamarind fruit extract

Indexed keywords

ALCOHOL; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CHOLESTEROL; COMPLEMENT; COMPLEMENT COMPONENT C2; LECTIN; PLANT EXTRACT; TAMARIND EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; COMPLEMENT SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FRUIT; HAMSTER; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INFLAMMATION; LYSIS; MALE; MEDIATOR; NONHUMAN; NORMAL HUMAN; RABBIT; SHEEP; TIME;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; COMPLEMENT C2; COMPLEMENT FACTOR B; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; CRICETINAE; FRUIT; HYPERLIPIDEMIAS; MALE; MESOCRICETUS; PLANT EXTRACTS; STATISTICS, NONPARAMETRIC; TAMARINDUS; TRIGLYCERIDES;

CRICETINAE; TAMARINDUS INDICA;

EID: 34447105168     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.02.008     Document Type: Article

References (49)

1. Blumenkratz N., and Assboe-Hansen G. New method for quantitative determination of uronic acids. Anal. Biochem. 54 (1973) 484-489
2. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Chan P.T., Fong W.P., Cheung Y.L., Huang Y., Ho W.K.K., and Chen Z.Y. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) for a high fat diet. J. Nutr. 129 (1999) 1094-1101
4. Dorfman S.E., Smith D.E., Osgood D.P., and Lichtenstein A.H. Study of diet-induced changes in lipoprotein metabolism in two strains of Golden-Syrian hamsters. J. Nutr. 133 (2003) 4183-4188
5. Dubey G.P., Dixit S.P., and Alok S. diabetes in rabbits and effect of herbal formulation D-400. Indian J. Pharmacol. 26 (1994) 225-226
6. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., and Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28 (1956) 350-356
7. Ewald R.A., Williams J.H., and Bowden D.H. Serum complement in the newborn. An investigation of complement activity in normal infants and in Rh and AB hemolytic disease. Vox Sang 6 (1961) 312-319
8. Ferriani V.P., Barbosa J.E., and de Carvalho I.F. Serum haemolytic classical and alternative pathways of complement in infancy: age-related changes. Acta Paediatr. Scand. 79 (1990) 322-327
9. Folin O., and Ciocalteau V. On tyrosine and tryptophane determinations in proteins. J. Biol. Chem. 73 (1927) 627-650
10. Geertinger P., and Sorensen H. Complement and atherosclerosis. Atherosclerosis 18 (1973) 65-77
11. Geleijnse J.M., Launer L.J., Hofman A., Pols H.A., and Witernan J.C. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch. Intern. Med. 159 (1999) 2170-2174
12. Hamuro J., Hadding U., and Bitter-Suermann D. Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biological activities. J. Immunol. 120 (1978) 438-444
13. Hansson G.K., Holm J., and Kral J.G. Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol. Microbiol. Immunol. Scand. 92 (1984) 429-435
14. Harrison R.A., and Lachamnn P.J. Complement technology. In: Weir D.M. (Ed). Handbook of Experimental Immunology vol. 1 (1986), Blackwell Scientific Publications, Oxford 39.1-39.4
15. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zuptphen Elderly Study. Lancet 342 (1993) 1007-1011
16. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S., Pekkarinen M., Simic B.S., Toshima H., Feskens E.J.M., Hollman P.C.H., and Katan M.B. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155 (1995) 381-386
17. Hollander W., Colombo M.A., Krkpatrick B., and Paddock J. Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis 34 (1979) 391-405
18. Horder M., and Rej R. Alanine transaminase. In: Bergmeyer H.U., Bergmeyer J., and Grasse M. (Eds). Methods of Enzymatic Analysis (1983), Verlag Chemic, Germany 444-456
19. Joisel F., Leroux-Nicollet I., Lebreton J.P., and Fontaine M. A hemolytic assay for clinical investigation of human C2. J. Immunol. Methods 29 (1983) 229-235
20. Kahlon T.S., Chow F.I., Sayre R.N., and Betschart A.A. Cholesterol-lowering in hamsters fed rice bran at various levels, defatted rice bran and rice bran oil. J. Nutr. 122 (1992) 513-519
21. Keli S.O., Hertog M.G., Feskens E.J., and Kromhout D. Dietary flavonoids, antoxidant vitamins, and incidence of stroke: the Zuptphen study. Arch. Intern. Med. 156 (1996) 637-642
22. Kidby D.K., and Davidson D.J. A convenient ferricyanide estimation of reducing sugars in the nanomole range. Anal. Biochem. 55 (1973) 3221-3325
23. Kingsley G.R. The direct biuret method for the determination of serum proteins as applied to photoelectric and visual colometry. J. Lab. Clin. 27 (1942) 840-845
24. Komutarin T., Azadi S., Butterworth L., Keil D., Chitsomboon B., Suttajit M., and Meade B.J. Extract of the seed coat of Tamarindus indica inhibits nitric oxide production by murine macrophages in vitro and in vivo. Food Chem. Toxicol. 42 (2004) 649-658
25. Ladeji O., Omekarah L., and Solomon M. Hypoglicemic properties of aqueous bark extract of Ceiba pentandra in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 84 (2003) 139-142
26. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
27. Martinello F., Soare S.M., Franco J.J., Santos A.C., Sugohara A., Garcia S.B., Curti C., and Uyemura S.A. Hypolipemic and antioxidant activities from Tamarindus indica L. pulp fruit extract in hypercholesterolemic hamsters. Food Chem. Toxicol. 44 (2006) 810-818
28. Mayer M.M. Complement and complement fixation. In: Kabat E.A., and Mayer M.M. (Eds). Experimental Immunochemistry (1971), Charles C. Thomas Publisher, USA 133-240
29. Moghadasian H.M. Experimental atherosclerosis. A historical overview. Life Sci. 70 (2002) 855-865
30. Nistor A., Bulla A., Filip D.A., and Radu A. The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68 (1987) 159-173
31. Oberholzer J., Yu D., Triponez F., Cretin N., Andereggen E., Mentha G., White D., Buehler L., Morel P., and Lou J. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model. Immunology 97 (1999) 173-180
32. Pasqui A.L., Bova G., Puccetti L., Bruni F., Pompella G., and Auteri A. Complement activation in hypercholesterolemia. Nutr. Metab. Cardiovasc. Dis. 10 (2000) 137-142
33. Paul E.W. Complement. In: Paul E.W. (Ed). Fundamental Immunology (1999), Lippincott-Raven Publishers, Philadelphia 967
34. Peters T., Biamont G.T., and Doumas B.T. Albumin in serum. In: Faulkner W.R., and Meites S. (Eds). Selected Methods of Clinical Chemistry vol. 9 (1982), AACC Press, Washington 319
35. Prince P.S., Menon V.P., and Pari L. Hypoglycemic activity of Syzigium cuminii seeds: effect on lipid peroxidation in alloxan diabetes rats. J. Ethnopharmacol. 61 (1998) 1-7
36. Pumthong G. Antioxidant Activity of Polyphenolic Compounds Extracted from Seed Coat of Tamarindus indica Linn (1999), Chiang Mai University, Thailand
37. Rej R., and Horder M. Aspartate aminotransferase. In: Bergmeyer H.U., Bergmeyer J., and Grasse M. (Eds). Methods of Enzymatic Analysis (1983), Verlag Chemic, Germany 416-443
38. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
39. Ross J.A., and Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 22 (2002) 19-34
40. Sreelekha T.T., Vijayakumar T., Ankanthil R., Vijayan K.K., and Nair M.K. Immunomodulatory effects of a polysaccharide from Tamarindus indica. Anticancer Drugs 4 (1993) 209-212
41. Sudjaroen Y., Haubner R., Würtele G., Hull W.E., Erben G., Spiegelhalder B., Changbumrung S., Bartsch H., and Owen R.W. Isolation and structure elucidation of phenolics antioxidants from Tamarind (Tamarindus indica L.) seeds and pericarp. Food Chem. Toxicol. 43 (2005) 1673-1682
42. Torzewski M., Torzewski J., Bowyer D.E., Waltenberger J., Fitzsimmons C., Hombach V., and Gabbert H.E. colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2448-2452
43. Vakeva A., Jauhiainen M., Ehnholm C., Lehto T., and Meri S. High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 82 (1994) 28-33
44. Vlaicu R., Niculescu F., Rus H.G., and Cristea A. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 55 (1985) 35-50
45. Vlaicu R., Niculescu F., Rus H.G., and Cristea A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 57 (1985) 163-177
46. Wallport M.J. Complement. First of two parts. NE J. Med. 344 (2001) 1058-1066
47. Wilson T.A., Nicolosi R.J., Delaney B., Chadwell K., Moolchandani V., Kotyla T., Ponduru S., Zheng G.H., Hess R., Knutson N., Curry L., Kolberg L., Goulson M., and Ostergren K. Reduced and high molecular weight barley β-glucans decrease plasma total and non-HDL-cholesterol in hypercholesterolemic Syrian Golden hamsters. J. Nutr. 134 (2004) 2617-2622
48. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Complement components, but not complement inhibitors, are upregulated in Atherosclerotic Plaques. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1214-1219
49. Zern T.L., West K.L., and Fernandez M.L. Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guines pigs. J. Nutr. 133 (2003) 2268-2272